Possible Treatment for Rare Vascular Disease
News Nov 30, 2016
In individuals with a rare genetic disorder that affects blood vessels, arteries and veins develop abnormal connections, causing bleeding in the skin, nose, and other organs. In most cases, the condition — hereditary haemorrhagic telangiectasia, or HHT — is due to mutations in two genes that regulate proteins in the endothelial cells lining the blood vessels. Treatment options are limited.
To better understand the disease mechanism, professor of cardiology Anne Eichmann and her co-authors studied the condition in mouse models. They found that deleting the genes in the animals led to vascular malformations similar to those seen in HHT patients. Next, by using a drug to inhibit a protein involved in cell growth (P13 kinase), the researchers reversed the condition in mice. If the finding is confirmed in human patients, it could lead to improved treatment for the disease, say the researchers.
Story from Yale Unviersity. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
Ola, R., Dubrac, A., Han, J., Zhang, F., Fang, J. S., Larrivée, B., … Eichmann, A. (2016). PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia. Nature Communications, 7,. doi:10.1038/ncomms13650
Worms Exhibit Fear and Respond to Anti-anxiety MedsNews
A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.READ MORE
Stem Cells in Menstrual Blood Could Help Diagnose EndometriosisNews
The Feinstein Institute for Medical Research scientists announced an experimental, rapid and non-invasive way to diagnose endometriosis, which may lead to earlier and more effective treatments for this disorder that affects approximately 176 million women globally.READ MORE